Satoru Kohgo

995 citations

35 papers · 812 indexed · h-index 15

Co-authors: Hiroaki Mitsuya Eiichi Kodama Hiroshi Ohrui Masao Matsuoka Kenji Kitano Hiroyuki Hayakawa Shirô Shigeta Noriyuki Ashida
Topics: HIV/AIDS drug development and treatment (28 papers)HIV Research and Treatment (14 papers)HIV/AIDS Research and Interventions (10 papers)
Cited by: Virology Infectious Diseases Hepatology
Journals: Nucleic Acids Research PLoS ONE Hepatology
Partner nations: Japan United States Malaysia

In The Last Decade

Satoru Kohgo

35 papers receiving 799 citations

Peers

Countries citing papers authored by Satoru Kohgo

Since Specialization

Citations

This map shows the geographic impact of Satoru Kohgo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoru Kohgo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoru Kohgo more than expected).

Fields of papers citing papers by Satoru Kohgo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoru Kohgo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoru Kohgo. The network helps show where Satoru Kohgo may publish in the future.

Co-authorship network of co-authors of Satoru Kohgo

This figure shows the co-authorship network connecting the top 25 collaborators of Satoru Kohgo. A scholar is included among the top collaborators of Satoru Kohgo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoru Kohgo. Satoru Kohgo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intraperitoneal administration of synthetic microRNA-214 elicits tumor suppression in an intraperitoneal dissemination mouse model of canine hemangiosarcoma 2022 ·Veterinary Research Communications ·(unknown),Atsushi Maeda,Yoshihito Ueno,Hiroki Sakai,Shintaro Kimura,(unknown),Satoru Kohgo,Kohei Yamada,Takashi Mori	5
2	Structural features in common of HBV and HIV-1 resistance against chirally-distinct nucleoside analogues entecavir and lamivudine 2020 ·Scientific Reports ·Y. Yasutake,Shin-ichiro Hattori,Noriko Tamura,Kouki Matsuda,Satoru Kohgo,Kenji Maeda,Hiroaki Mitsuya	19
3	CMCdG, a Novel Nucleoside Analog with Favorable Safety Features, Exerts Potent Activity against Wild-Type and Entecavir-Resistant Hepatitis B Virus 2019 ·Antimicrobial Agents and Chemotherapy ·Nobuyo Higashi‐Kuwata,Sanae Hayashi,Debananda Das,Satoru Kohgo,Shuko Murakami,Shin-ichiro Hattori,Shuhei Imoto,David Venzon,Kamalendra Singh,Stefan G. Sarafianos,Yasuhito Tanaka,Hiroaki Mitsuya	15
4	Active-site deformation in the structure of HIV-1 RT with HBV-associated septuple amino acid substitutions rationalizes the differential susceptibility of HIV-1 and HBV against 4ʹ-modified nucleoside RT inhibitors 2019 ·Biochemical and Biophysical Research Communications ·Y. Yasutake,Shin‐ichiro Hattori,Noriko Tamura,Kouki Matsuda,Satoru Kohgo,Kenji Maeda,Hiroaki Mitsuya	8
5	Synthesis and evaluation of the anti-hepatitis B virus activity of 4′-Azido-thymidine analogs and 4′-Azido-2′-deoxy-5-methylcytidine analogs: structural insights for the development of a novel anti-HBV agent 2019 ·Nucleosides Nucleotides & Nucleic Acids ·(unknown),(unknown),(unknown),Hiroki Kumamoto,Manabu Aoki,Masayuki Amano,Satoru Kohgo,Debananda Das,Kazuhiro Haraguchi,Hiroaki Mitsuya,Shuhei Imoto	1
6	HIV-1 with HBV-associated Q151M substitution in RT becomes highly susceptible to entecavir: structural insights into HBV-RT inhibition by entecavir 2018 ·Scientific Reports ·Y. Yasutake,Shin-ichiro Hattori,Hironori Hayashi,Kouki Matsuda,Noriko Tamura,Satoru Kohgo,Kenji Maeda,Hiroaki Mitsuya	16
7	Pharmacokinetic properties of a novel inosine analog, 4′-cyano-2′-deoxyinosine, after oral administration in rats 2018 ·PLoS ONE ·Mai Hashimoto,Kazuaki Taguchi,(unknown),Satoru Kohgo,Shuhei Imoto,Keishi Yamasaki,Hiroaki Mitsuya,Masaki Otagiri	2
8	The High Genetic Barrier of EFdA/MK-8591 Stems from Strong Interactions with the Active Site of Drug-Resistant HIV-1 Reverse Transcriptase 2018 ·Cell chemical biology ·Yuki Takamatsu,Debananda Das,Satoru Kohgo,Hironori Hayashi,(unknown),Stefan G. Sarafianos,Hiroaki Mitsuya,Kenji Maeda	22
9	Potent Activity of a Nucleoside Reverse Transcriptase Inhibitor, 4′-Ethynyl-2-Fluoro-2′-Deoxyadenosine, against Human Immunodeficiency Virus Type 1 Infection in a Model Using Human Peripheral Blood Mononuclear Cell-Transplanted NOD/SCID Janus Kinase 3 Knockout Mice 2009 ·Antimicrobial Agents and Chemotherapy ·Shin-ichiro Hattori,(unknown),Hirotomo Nakata,Hideki Harada,Shinya Suzu,Noriyuki Ashida,Satoru Kohgo,Hiroyuki Hayakawa,Hiroaki Mitsuya,Seiji Okada	43
10	2′-Deoxy-4′-C-ethynyl-2-halo-adenosines active against drug-resistant human immunodeficiency virus type 1 variants 2008 ·The International Journal of Biochemistry & Cell Biology ·Atsushi Kawamoto,Eiichi Kodama,Stefan G. Sarafianos,Yasuko Sakagami,Satoru Kohgo,Kenji Kitano,Noriyuki Ashida,Yuko Iwai,Hiroyuki Hayakawa,Hirotomo Nakata,(unknown),(unknown),(unknown)	99
11	2′-Deoxy-4′-C-Ethynyl-2-Fluoroadenosine: A Nucleoside Reverse Transcriptase Inhibitor with Highly Potent Activity Against Wide Spectrum of HIV-1 Strains, Favorable Toxic Profiles, and Stability in Plasma 2007 ·Nucleosides Nucleotides & Nucleic Acids ·Hiroshi Ohrui,Satoru Kohgo,Hiroyuki Hayakawa,Eiichi Kodama,Masao Matsuoka,Tomohiro Nakata,Hiroaki Mitsuya	42
12	Creation of Low Toxic Reverse-transcriptase Inhibitory Nucleosides that Prevent the Emergence of Drug-resistant HIV Variants 2006 ·Journal of Synthetic Organic Chemistry Japan ·Hiroshi Ohrui,Hiroyuki Hayakawa,Satoru Kohgo,Masao Matsuoka,Eiichi Kodama,Hiroaki Mitsuya	8
13	2′-Deoxy-4′-C-ethynyl-2-fluoroadenosine: A nucleoside reverse transcriptase inhibitor with highly potent activity against all HIV-1 strains, favorable toxic profiles and stability in plasma 2006 ·Nucleic Acids Symposium Series ·Hiroshi Ohrui,Satoru Kohgo,Hiroyuki Hayakawa,Eiichi Kodama,Masao Matsuoka,Tomohiro Nakata,(unknown)	14
14	Design, Efficient Synthesis, and Anti‐HIV Activity of 4′‐C‐Cyano‐ and 4′‐C‐Ethynyl‐2′‐deoxy Purine Nucleosides 2004 ·Nucleosides Nucleotides & Nucleic Acids ·Satoru Kohgo,Kohei Yamada,Kenji Kitano,Yuko Iwai,Shinji Sakata,Noriyuki Ashida,Hiroyuki Hayakawa,(unknown),Eiichi Kodama,Masao Matsuoka,Hiroaki Mitsuya,Hiroshi Ohrui	39
15	Synthesis of 4′-C-Ethynyl and 4′-C-Cyano Purine Nucleosides from Natural Nucleosides and Their Anti-HIV Activity 2003 ·Nucleosides Nucleotides & Nucleic Acids ·Satoru Kohgo,Kohei Yamada,Kenji Kitano,Shinji Sakata,Hiroyuki Hayakawa,(unknown),Eiichi Kodama,Masao Matsuoka,Hiroaki Mitsuya,Hiroshi Ohrui	3
16	Synthesis of the L-Enantiomer of 4'-C-Ethynyl-2'-deoxycytidine 2001 ·Bioscience Biotechnology and Biochemistry ·Satoru Kohgo,Hiroaki Mitsuya,Hiroshi Ohrui	6
17	Synthesis of 4'-substituted nucleosides and their biological evaluation 1999 ·Nucleic Acids Symposium Series ·Satoru Kohgo,Eiichi Kodama,Shirô Shigeta,Mineo Saneyoshi,H. Machida,Hiroshi Ohrui	6
18	Synthesis of 4′-C-Ethynyl-β-D-arabino- and 4′-C-Ethynyl-2′-deoxy-β-D-ribo- pentofuranosyl Pyrimidines, and Their Biological Evaluation 1999 ·Bioscience Biotechnology and Biochemistry ·Satoru Kohgo,(unknown),Hiroshi Ohrui	10
19	Synthesis of 4′-C-Ethynyl-β-D-ribo-pentofuranosyl Pyrimidines 1999 ·Bioscience Biotechnology and Biochemistry ·Ryohei Yamaguchi,T. IMANISHI,Satoru Kohgo,(unknown),Hiroshi Ohrui	8
20	Chiral Discrimination of 2′-Deoxy-l-cytidine andl-Nucleotides by Mouse Deoxycytidine Kinase: Low Stereospecificities for Substrates and Effectors 1997 ·Biochemical and Biophysical Research Communications ·(unknown),Satoru Kohgo,(unknown),(unknown),(unknown),Takeo Kawaguchi,(unknown),(unknown)	9

About Satoru Kohgo

Satoru Kohgo is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 35 papers that have together received 812 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (28 papers), HIV Research and Treatment (14 papers) and HIV/AIDS Research and Interventions (10 papers). The work is most often cited by research in Virology (434 citations), Infectious Diseases (620 citations) and Hepatology (78 citations). Satoru Kohgo has collaborated with scholars based in Japan, United States and Malaysia. Frequent co-authors include Hiroaki Mitsuya, Eiichi Kodama, Hiroshi Ohrui, Masao Matsuoka, Kenji Kitano, Hiroyuki Hayakawa, Shirô Shigeta, Noriyuki Ashida, Hirotomo Nakata and Stefan G. Sarafianos. Their work appears in journals such as Nucleic Acids Research, PLoS ONE and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact